Anti-CXCL2 antibody [EPR28746-89]
- BOND RX™ Validated
- 20ul selling size
- Recombinant
- RabMAb
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal CXCL2 antibody. Suitable for Dot, Flow Cyt (Intra), IHC-P, ICC/IF, WB, IP and reacts with Recombinant fragment - Mouse, Mouse samples.
View Alternative Names
GRO2, GROB, MIP2A, SCYB2, CXCL2, C-X-C motif chemokine 2, Growth-regulated protein beta, Macrophage inflammatory protein 2-alpha, Gro-beta, MIP2-alpha
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CXCL2 antibody [EPR28746-89] (AB317569)
Immunohistochemical analysis of paraffin-embedded (A) Raw 264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) treated with lipopolysaccharide (LPS, 100 ng/mL) and Brefeldin A (300 ng/mL) for 4 hours. (B) Untreated Raw 264.7. tissue labeling CXCL2 with ab317569 at 1/500 (0.986 ug/ml) dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Positive staining in (A) Raw 264.7 treated with lipopolysaccharide (LPS, 100 ng/mL) and Brefeldin A (300ng /mL) for 4 hours. No staining in (B) untreated Raw 264.7.
The section was incubated with ab317569 for 30 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument.
Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CXCL2 antibody [EPR28746-89] (AB317569)
Immunohistochemical analysis of paraffin-embedded (A) Mouse colon of Crohn's disease model. (B) Mouse normal colon. tissue labeling CXCL2 with ab317569 at 1/500 (0.986 ug/ml) dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Positive staining in mouse colon of Crohn's disease model, no staining in mouse normal colon.
The section was incubated with ab317569 for 30 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument.
Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-CXCL2 antibody [EPR28746-89] (AB317569)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized Raw 264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) cells labelling CXCL2 with ab317569 at 1/100 (4.93 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 2 ug/ml dilution (Green).
Confocal image showing cytoplasmic staining in Raw 264.7 cells (shown in green) treated with lipopolysaccharide (LPS, 100 ng/ml) and Brefeldin A (300ng/ml) for 4 hours. The counterstain was observed in magenta. Nuclear DNA was labeled with DAPI (shown in blue). Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).
ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 2.5ug/ml dilution (Magenta). The Nuclear counterstain was DAPI (Blue).
Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2 ug/ml dilution.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CXCL2 antibody [EPR28746-89] (AB317569)
Immunohistochemical analysis of paraffin-embedded (A) Mouse lung treated with lipopolysaccharide (LPS, 1 ug/mL) and Brefeldin A (1 ug/mL) for 16 hours. (B) Untreated mouse lung. tissue labeling CXCL2 with ab317569 at 1/500 (0.986 ug/ml) dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Positive staining in mouse lung treated lipopolysaccharide (LPS, 1 ug/mL) and Brefeldin A (1 ug/mL) for 16 hours. Nearly no staining in (B) untreated mouse lung.
The section was incubated with ab317569 for 30 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument.
Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-CXCL2 antibody [EPR28746-89] (AB317569)
Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized RAW 264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) treated with 100ng/mL LPS and 300ng/mL BFA for 4h (Red) / Untreated control (Dotted red) cells labelling CXCL2 with ab317569 at 1/500 dilution (0.1ug)/Red (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue).
Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/5000 dilution was used as the secondary antibody.
- IP
Supplier Data
Immunoprecipitation - Anti-CXCL2 antibody [EPR28746-89] (AB317569)
CXCL2 was immunoprecipitated from 0.35 mg RAW 264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) treated with 100ng/mL LPS and 300ng/ml BFA for 4h whole cell lysate with ab317569 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab317569 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution.
Lane 1 : RAW 264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) treated with 100ng/mL LPS and 300ng/ml BFA for 4h whole cell lysate
Lane 2 : ab317569 IP in RAW 264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) treated with 100ng/mL LPS and 300ng/ml BFA for 4h whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab317569 in RAW 264.7 treated with 100ng/mL LPS and 300ng/ml BFA for 4h whole cell lysate
All lanes:
Immunoprecipitation - Anti-CXCL2 antibody [EPR28746-89] (ab317569) at 1/30 dilution
All lanes:
RAW 264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) treated with 100ng/mL LPS and 300ng/ml BFA for 4h whole cell lysate at 3 µg
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-CXCL2 antibody [EPR28746-89] (AB317569)
The expression of CXCL2 is upregulated in response to LPS treatment (PMID : 31852751).
The identity of the bands between 37 kDa and 75 kDa are unknown.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
All lanes:
Western blot - Anti-CXCL2 antibody [EPR28746-89] (ab317569) at 1/1000 dilution
Lane 1:
Untreated RAW 264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate at 80 µg
Lane 2:
RAW 264.7 treated with 100ng/mL LPS and 300ng/ml BFA for 4h whole cell lysate at 80 µg
Lane 3:
Untreated J774A.1 (mouse reticum cell sarcoma monocyte/macrophage ) whole cell lysate at 80 µg
Lane 4:
J774A.1 treated with 100ng/mL LPS for 3h, 300ng/ml BFA was then added for additional 3h whole cell lysate at 80 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 11 kDa,36 kDa
false
Exposure time: 180s
- Dot
Supplier Data
Dot Blot - Anti-CXCL2 antibody [EPR28746-89] (AB317569)
Dot blot analysis of CXCL2 using ab317569 at 1 : 1000 (0.493 ug/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1 : 100,000 dilution.
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
This antibody does not cross-react with mouse CXCL1 and CLCX3.
In dot blot, anti-6X His tag® antibody [EPR20547] - ChIP Grade (ab213204) staining at 1/5000 dilution.
In dot blot, anti-GST antibody [EPR4236] (ab111947) (1 : 1000) staining at 1/1000 dilution.
All lanes:
Dot Blot - Anti-CXCL2 antibody [EPR28746-89] (ab317569) at 1/1000 dilution
Lane 1:
His-tagged mouse CXCL1 recombinant protein
Lane 2:
No tagged mouse CXCL2 recombinant protein
Lane 3:
His/GST-tagged mouse CXCL3 recombinant protein
Secondary
All lanes:
Dot Blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
false
Related conjugates and formulations (1)
-
Anti-CXCL2 antibody [EPR28746-89] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CXCL2 attracts and activates neutrophils as part of the innate immune response. It acts independently not as part of a larger complex to provoke a chemotactic response guiding neutrophils to areas of tissue injury. CXCL2 also promotes the release of other cytokines and enzymes that contribute to inflammation. Its activity is mediated through its interaction with receptors like CXCR2 on target cell surfaces.
Pathways
CXCL2 is involved in inflammatory signaling and leukocyte migration. It holds importance in the chemokine signaling pathway which regulates leukocyte trafficking. CXCL2 interacts with proteins like CXCR2 influencing the inflammation process by activating downstream kinases and other signal transduction molecules such as mitogen-activated protein kinases (MAPKs).
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com